Lv1
40 积分 2020-04-14 加入
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
17天前
已完结
Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide 1 in Healthy Individuals
1个月前
已完结
Dose‐dependent efficacy of the glucose‐dependent insulinotropic polypeptide ( GIP) receptor antagonist GIP (3‐30) NH 2 on GIP actions in humans
1个月前
已完结
Dissociable hindbrain GLP1R circuits for satiety and aversion
1个月前
已完结
Semaglutide drives weight loss through cAMP-dependent mechanisms in GLP1R-expressing hindbrain neurons
1个月前
已完结
The evolving landscape of obesity pharmacotherapy
1个月前
已完结
The suppression effects of feeding and mechanisms in CRF system of animals
3个月前
已完结
Urocortin 1 reduces food intake and ghrelin secretion via CRF2 receptors
3个月前
已完结
Human Urocortin 2, a Corticotropin-Releasing Factor (CRF)2 Agonist, and Ovine CRF, a CRF1 Agonist, Differentially Alter Feeding and Motor Activity
3个月前
已完结
Urocortins: emerging metabolic and energy homeostasis perspectives
3个月前
已完结
皖公网安备34019202002308
